CompletedNot Applicable

Novel Intervention for Amphetamine-type Stimulants Addiction

China60 participantsStarted 2016-07

Plain-language summary

The repetitive transcranial magnetic stimulation (rTMS) will be used to treat amphetamine-type stimulant (ATS) addiction.

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorders * Dextromanual Exclusion Criteria: * Have a disease that affect cognitive function such as history of head injury, cerebrovascular disease, epilepsy, etc * Have cognitive-promoting drugs in the last 6 months * Other substance abuse or dependence in recent five years (except nicotine) * Mental impairment, Intelligence Quotient (IQ) \< 70 * Mental disorders * Physical disease

What they're measuring

Change from Baseline Craving for ATS assessed by Visual Analog Scales (VAS) at 1 month

Timeframe: Baseline and 1 month

Trial details

NCT IDNCT02713815

SponsorShanghai Mental Health Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-07

View on ClinicalTrials.gov More Amphetamine Addiction trials